CYCLACEL PHARMACEUTICALS INC (CYCC)
Institutional ownership reported to the SEC as of Q3 2025, across 28 quarters.
1
Reporting holders
$2
Reported value
0.0%
Held as options
-12
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| OSAIC HOLDINGS, INC. | $2 | 8 | 0.00% | 2q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q3 2025 | 1 | $2 | 8 | 0 | 0 | 0 | 0.0% |
| Q2 2025 | 13 | $86.6K | 262,257 | 13 | 0 | 0 | 0.0% |
| Q1 2025 | 21 | $454.1K | 1,626,481 | 5 | 6 | 1 | 0.0% |
| Q4 2024 | 17 | $259.3K | 689,761 | 3 | 5 | 0 | 0.0% |
| Q3 2024 | 14 | $186.2K | 188,082 | 2 | 3 | 2 | 0.0% |
| Q2 2024 | 14 | $331.0K | 204,330 | 4 | 1 | 3 | 0.0% |
| Q1 2024 | 10 | $54.1K | 25,630 | 1 | 3 | 0 | 0.0% |
| Q4 2023 | 11 | $147.8K | 55,340 | 11 | 0 | 0 | 0.0% |
| Q3 2023 | 19 | $217.4K | 616,218 | 1 | 3 | 4 | 0.0% |
| Q2 2023 | 21 | $900.3K | 1,530,383 | 1 | 2 | 5 | 0.0% |
| Q1 2023 | 19 | $902.8K | 1,559,556 | 0 | 1 | 5 | 1.4% |
| Q4 2022 | 20 | $1.1M | 1,585,765 | 5 | 4 | 4 | 1.1% |
| Q3 2022 | 26 | $3.4M | 2,328,903 | 10 | 8 | 4 | 0.5% |
| Q2 2022 | 22 | $2.4M | 2,106,976 | 4 | 7 | 4 | 6.2% |
| Q1 2022 | 25 | $10.1M | 3,317,374 | 2 | 6 | 8 | 0.0% |
| Q4 2021 | 29 | $12.8M | 3,257,635 | 5 | 7 | 5 | 1.2% |
| Q3 2021 | 30 | $19.8M | 3,691,029 | 6 | 8 | 8 | 1.8% |
| Q2 2021 | 28 | $24.2M | 4,084,393 | 6 | 7 | 11 | 0.0% |
| Q1 2021 | 32 | $29.2M | 4,108,357 | 20 | 6 | 4 | 0.0% |
| Q4 2020 | 15 | $12.8M | 1,641,853 | 9 | 1 | 1 | 0.0% |
| Q3 2020 | 7 | $756.0K | 207,116 | 2 | 2 | 1 | 0.0% |
| Q2 2020 | 9 | $1.6M | 333,819 | 9 | 0 | 0 | 0.0% |
| Q1 2020 | 9 | $607.5K | 1,579,148 | 1 | 2 | 2 | 0.0% |
| Q4 2019 | 11 | $1.1M | 1,711,710 | 2 | 3 | 2 | 0.0% |
| Q3 2019 | 11 | $605.2K | 1,527,732 | 3 | 1 | 1 | 0.0% |
| Q2 2019 | 11 | $835.8K | 1,549,566 | 3 | 4 | 1 | 0.0% |
| Q1 2019 | 13 | $833.2K | 889,080 | 4 | 2 | 4 | 0.0% |
| Q4 2018 | 12 | $320.4K | 531,681 | 2 | 0 | 0 | 0.0% |